CD19+CD11c+T-bet+ B cells in myasthenia gravis: a potential biomarker
This study establishes ABCs and NF-κB/c-Rel signaling as central contributors to AChR-MG immunopathology. Therefore, ABCs may serve as complementary biomarkers for clinical stratification.
Authors
- Yiye Wang (ORCID: https://orcid.org/0000-0002-2880-3425)
- Ruihua Sun
- Yaru Lu (ORCID: https://orcid.org/0000-0003-3836-8516)
- Kai Ma (ORCID: https://orcid.org/0000-0002-2561-5955)
- Huimin Shen (ORCID: https://orcid.org/0000-0002-5758-9202)
- Qian Ma (ORCID: https://orcid.org/0000-0002-3272-9723)
- Yaqiong Li (ORCID: https://orcid.org/0009-0001-6512-4392)
- Jiewen Zhang (ORCID: https://orcid.org/0000-0001-5355-3256)
- Ying Zhao (ORCID: https://orcid.org/0000-0003-1839-8849)
Institutions
- Sun Yat-sen University (CN)
- Zhengzhou University (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3389/fneur.2025.1623066
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province